Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: A comparative study

Liver

Volumn 19, Issue 1, 1999, Pages 58-68

  Tiniakos, Dina G ^a,b   Brunt, Elizabeth M ^a,c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

Dysplastic; Markers; Nodules; Proliferation

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

ADULT; ARTICLE; BILE; CELL DENSITY; CELL PROLIFERATION; CELL REGENERATION; CLEAR CELL CARCINOMA; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; EOSINOPHILIA; FEMALE; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE;

ADULT; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0032945836     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00011.x     Document Type: Article

References (46)

1. TERADA T, TERASAKI S, NAKANUMA Y. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy. Cancer 1993; 72: 1551-6.
2. ARAKAWA M, KAGE M, SUGIHARA S, et al. Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver: observations in five cases. Gastroenterology 1986; 91: 198-208.
3. KAJI K, TERADA T, NAKANUMA Y. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study. Am J Gastroenterol 1994; 89: 903-8.
4. NAKANUMA Y, TERADA T, UEDA K, et al. Adenomatous hyperplasia of the liver as a precancerous lesion. Liver 1993; 13: 1-9.
5. TAKAYAMA T, MAKUUCHI M, HIROHASHI S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990; 336: 1150-3.
6. NAKANUMA Y, TERADA T, TERASKI S, et al. 'Atypical adenomatous hyperplasia' in liver cirrhosis: low-grade hepato-cellular carcinoma or borderline lesion? Histopathology 1990; 17: 27-35.
7. LEBAIL B, BELLEANNEE G, BERNARD P H, et al. Adenomatous hyperplasia in cirrhotic livers: histological evaluation, cellular density, and proliferative activity of 35 macronodular lesions in the cirrhotic expiants of 10 adult French patients. Hum Pathol 1995; 26: 897-906.
8. LENCIONI R, CARAMELLA P, BARTOLOZZI C, DICOSCIO G. Long-term follow-up study of adenomatous hyperplasia in liver cirrhosis. Italian J Gastroenterol 1994; 26: 163-8.
9. MION F, GROZEL L, BOILLOT O, et al. Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinoma. Gastroenterology 1996; 111: 1587-92.
10. THEISE N D, SCHWARTZ M, MILLER C, THUNG S N. Macroregenerative nodules and hepatocellular carcinoma in 44 sequential adult liver explants with cirrhosis. Hepatology 1992; 16: 949-55.
11. FERRELL L, WRIGHT T, LAKE J, et al. Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers. Hepatology 1992; 16: 1372-1381.
12. HYTIROGLOU P, THEISE N D, SCHWARTZ M, et al. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues in classification and nomenclature. Hepatology 1995; 21: 703-8
13. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
14. FURUYA K, NAKAMURA H, YAMAMOTO Y, et al. Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 1988; 61: 99-105.
15. TERADA T, UEDA K, NAKANUMA Y. Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers. Vichows Archiv-A, Path Anat and Histopath 1993; 422: 381-8.
16. TERADA T, NAKANUMA Y. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen. Cancer 1992; 70: 591-8.
17. SAKAMOTO M, HIROHASHI S, SHIMOSATO Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22: 172-8.
18. EQUCHI A, NAKASHIMA O, OKUDAIRA S, et al. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma. Hepatology 1992; 15: 843-8.
19. FERRELL L D, CRAWFORD J M, DHILLON A P, et al. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 1993; 17; 1113-23.
20. WATANABE S, OKITA K, HARADA T, et al. Morphologic studies of the liver cell dysplasia. Cancer 1983; 51: 2197-205.
21. ANTHONY P P, VOGEL C L, BARKER L F. Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973; 26: 217-23.
22. THEISE N D, MARCELIN K, GOLDFISCHER M, et al. Low proliferative activity in macroregenerative nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis. Liver 1996; 16: 134-9.
23. AIHARA T, NOGUCHI S, SASAKI Y, et al. Clonal analysis of regenerative nodules in hepatitis C-virus induced liver cirrhosis. Gastroenterology 1994; 107: 1805-11.
24. YASUI H, HINO O, OHTAKE K, et al. Clonal growth of hepatitis B virus - integrated hepatocytes in cirrhotic liver nodules. Cancer Res 1992; 52: 6810-4.
25. TSUDA H, HIROHASHI S, SHIMOSATO Y, et al. Clonal origin of atypical adenomatous hyperplasia and clonal identity with hepatocellular carcinoma. Gastroenterolgy 1988; 95: 1664-6.
26. ORSATTI G, THEISE N, THUNG S N, PARONETTO F. DNA image cytometric analysis of macroregenerative nodule (adenomatous hyperplasia) of the liver: evidence in support of their preneoplastic nature. Hepatology 1993; 17: 621-7.
27. AOKI K, SAKAMOTO S, HIROHASHI S. Nucleolar organizer regions in small nodular lesions representing early stages of human hepatocarcinogenesis. Cancer 1994; 73: 289-93.
28. SEKI S, SAKAGUCHI H, KAWAKITA N, et al. Identification and fine structure of proliferating hepatocytes in malignant and non-malignant liver diseases by use of a monoclonal antibody against DNA polymerase alpha. Hum Pathol 1990; 21: 1020-30.
29. FACCIOLI S, CHIECO P, GRAMANTIERI L, et al. Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver. Mod Pathol 1996; 9: 120-5.
30. ADACHI E, HASHIMOTO H, TSUNEYOSHI M. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia. Cancer 1993; 72: 2902-9.
31. ZHAO M, ZHANG N X, Du Z Y, LAISUE J A, et al. Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguished by karyometry and PCNA labeling, and their features resemble distinct grades of hepatocellular carcinoma. Histol Histopathol 1994; 9: 73-83.
32. THOMAS R M, BERMAN J J, YETTER R A, et al. Liver cell dysplasia: A DNA aneuploid lesion with distinct morphologic features. Hum Pathol 1992; 23: 496-503.
33. RUBIN E, DEROSE P B, COHEN C. Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma. Mod Pathol 1994; 7: 677-80.
34. GANNE-CARRIE N, CHASTANG C, CHAPEL F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996; 23: 1112-8.
35. BORZIO M, BRUNO S, RONCALLI M, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 1995; 108: 812-7.
36. LEE R G, TSAMANDAS A C, DEMETRIS A J. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case - control study, pathological analysis, and pathogenetic hypothesis. Hepatology 1997; 26: 1415-22.
37. NATAJARAN S, THEISE N D, THUNG S, et al. Large-cell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis. Am J Surg Pathol 1997; 21: 312-8.
38. MITCHELL D G, RUBIN R, SIEGELMAN E, BURK D L, et al. Hepatocellular carcinoma within siderotic regenerative nodules; appearance as a nodule within a nodule on MR images. Radiology 1991; 178: 101-3.
39. MATSUI O, KADOYA M, KAMEYAMA T et al. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 1989; 173: 123-6.
40. KELLEHER L, MAGEE H M, DERVAN P A. Evaluation of cell proliferation antibodies reactive in paraffin sections. Applied Immunohistochemistry 1994; 28: 164-70.
41. MCCORMICK D, YU C, HOBBS C, HALL P A. The relevance of antibody concentration to the immunohistochemical quantification of cell proliferation-associated antigens. Histopathology 1993; 22: 543-7.
42. MCCORMICK D, HALL P A. The complexities of proliferating cell nuclear antigen. Histopathology 1992; 21: 591-4.
43. SCHAFFNER F, THUNG S N. Clinicopathologic conferences. Hepatology 1994; 19: 534-7.
44. SNOVER D. Thoughts on the development of hepatocellular carcinoma in cirrhotic and non-cirrhotic livers. Editorial. Am J Clin Pathol 1996; 105: 3-5.
45. MAEDA T, TAKENAKA K. ADACHI E, et al. Small hepatocellular carcinoma of single nodular type: a specific reference to its surrounding cancerous area undetected radiologically and macroscopically. J Surg Oncol 1995; 60: 75-9.
46. DEUGNIER YM, CHARALAMBOUS P. LEQUILLENC D, et al. Preneoplastic significance of hepatic iron free foci in genetic hemochromatosis: A study of 185 patients. Hepatology 1993; 18: 1363-9.